Nephrotic Syndrome and Acute Nephritic Syndrome: CBD (4) Supervised by Presented by
Nephrotic Syndrome and Acute Nephritic Syndrome: CBD (4) Supervised by Presented by
Nephrotic Syndrome and Acute Nephritic Syndrome: CBD (4) Supervised by Presented by
No history of SOB
No history of jaundice or eating out
Other systemic review unremarkable
No known allergies to medications or foods
He is compliant to medications, following up in outpatient
department
Antenatal history: product of full term, spontaneous vaginal
deliver of uncomplicated pregnancy.
Diagnosed at age of 7 months when presented with
generalized edema.
Multiple admissions as relapses, last one was a year ago.
Diet: family diet.
Vaccines: vaccinated fully, no extra vaccines
Development: up to age, attending school with good performance
Family history: has other 6 healthy siblings, no consanguinity, no
similar illness in the family.
Social history: lives in kilo 14, small apartment, father is a
salesman, mother is a stay-at home mom, low socioeconomic
status.
Clinical Presentation
Vomiting
cough
Abdominal
distension
RUQ pain
diarrhea
Generalized edema history DDx:
CHF: Failure to thrive, SOB, cough, Hx of heart disease
Nephritic syndrome: tea like urine, low urine output, puffiness around the
eyes
Nephrotic syndrome: puffiness around eyes, frothy urine, abdominal
distention
Liver damage, acute hepatitis : jaundice, dark urine, black tarry stool,
pain/lump in abdomen, itching, petechiae, bleeding tendency
Allergic: lips, eyelids, face involvement, urticaria, wheezing
Malnutrition: Anorexia, lethargy, diarrhea, vomiting, decreased growth,
frequent infections, anemia (palpitations, fatigue)
Drug induced: Prednisolone decreased growth, central fat, peripheral
edema, increased risk of infection, hypertension
Examination
Vitals:
– RR: 20 bpm (N:18– 25)
– Temp:37 C oral (N:35.5 – 37.5)
– BP: 154/91 mmHg (N: SBP: 102-120
DBP: 61-80 mmHg)
– HR: 72 bpm brachial (N: 75 – 118)
– SpO2 : 100
Growth Parameters
– Weight: 47.7 kg
– Height: 150 cm
– BMI: 21.2
Examination
• Lipid profile:
Cholesterol: 4.77 mmol/L (RR: 0 – 5.2 mmol/L)
Triglycerides: 0.77 mmol/L (RR: 0.3 – 2.3 mmol/L)
HDL: 1.36 mmol/L (RR:0.3– 2.3 mmol/L)
LDL: 2.82 mmol/L (RR: 0 - 3.57 mmol/L)
• Complement
C3: 0.91 g/L (RR:0.75 – 1.65 g/L)
C4: 0.275 g/L (RR: 0.2 – 0.6 g/L)
Investigation
Radiological findings
U/S: Kidney Biopsy
Orthostati 24 hr urine
Nephrotic > Transient
c
syndrome 1g/m2/da proteinuri
proteinuri
y a
a
NEPHROTIC SYNDROME
Proteinuria Hyperlipidemia
• Hypercholestriemia
• Nephrotic proteinuria
• > 250 mg / dL
• > 40 mg/ m2/ hour
• Xanthelsma &
• or 1g / m2/ day [24
Xanthoma
hours]
• frothy urine
Nephrotic
Syndrome
Hypoproteinemia Edema
• Mainly serum albumin
• Hypoalbuminaemia
• < 3 g / dL
Pathophysiology
Reduced
intravascular oncotic
pressure
Increased Decrease
Increased serum TG& LDL aldosterone renal
function
95 % idiopathic
5 % : secondary
Histological classification
Hypertension
Malnutrition
Urinalysis
For diagnosis
Biochemical
CBC
Investigation
Lupus antibody
serology
Age Atypical
Gross hematuria
• Age:
Before treatment
• < 3 mo:
Renal failure
congenital
Renal biopsy Indications Low complement
• 3-12 mo:
infantile
Steroid • Response
resistance
After treatment • Lab:
Relapse • Renal failure
• Gross hematuria
• Low
complement
Fever
Transient
Exercise
proteinuria
Nephrotic
+ Edema
syndrome
+ve
Morning [am]
24 hr urine
- Edema > 1 g / m / 24 hr
collection
+ Dipstick
Nephrotic syndrome
Evening [pm] Orthostatic
Management
Supportive Specific
treatment treatment
Treatment of Treatment of
Diet Immunization Prednisone
edema complication
Thrombo-
Long-term
Salt restriction Diuretics Infection Hypertension embolic Varicella
steroids
episodes
Prevent
H. Albumin
CCB immobilizatio Vitamin D 125 Neisseria
infusion
n
Antiplatelet
HiB
(aspirin)
Anticoagulant Influenza
(LMWH) (annually)
Long-Term Monitoring
Ongoing use and adjustment of diuretics and angiotensin antagonists
are done according to the amount of edema and proteinuria that a patient
has.
Follow-up care in patients with nephrotic syndrome also includes
immunizations and monitoring for corticosteroid toxicity.
Oral Prednisolone should be started at:
– 60 mg/ m²/day everyday for 4 – 6 weeks
Cyclosporine
60 mg/ m²/day
4 weeks FSGS ACEI
+/- diuretics
No response Resistance
Atypical Age
Atypical
Renal biopsy
response
Atypical Lab
Steroid sensitive nephrotic syndrome
Relapse: Recurrence of significant proteinuria: +2 or more in 3 consecutive
days
Infrequent relapse
– Once yearly (short course of treatment )
– 60 mg/m2 or 2 mg/kg every day from 2 weeks.
– then decrease the dose to 40 mg/m2 giving on alternative day from 4 weeks.
– Then gradually decrease the dose over 4-6 weeks.
Vitals :
BP:123/72(high)
RR:28
Temp:37
HR:110
Hematuria
Glomerular Non
cause Glomerular
LUT
Tubular -trauma Increase
Non
(mainly microscopic -infections pathologic hemolysis Increase in
with history of HUS bleeding
al : tendency
polyuria ) Rhabdomyolysis
Food
-infection Drugs
-structural Urate
-trauma crystals in
-sickle cell anemia infant
Hematuria Approach:
Urinalysis
Negative Positive
for blood for blood
deposited in glomerular
streptococcal latent Antigen + Antibody + acute
antibodies basement membrane
infection period C3 complexes (subepithelial humps) inflammation